<DOC>
	<DOCNO>NCT00212212</DOCNO>
	<brief_summary>This study conduct determine patient cirrhosis ( liver disease ) selenium deficient . The effect supplementation two chemical form selenium plasma selenium biomarkers determine correlated severity liver disease .</brief_summary>
	<brief_title>Selenium Supplementation Patients With Cirrhosis</brief_title>
	<detailed_description>Selenium essential nutrient play role oxidant defense , among function . There much interest role selenium may play several disease process . It possible certain disease result selenium deficiency form selenium take normal diet . We propose measure selenium biomarkers associate supplemental intake 200 400 µg selenium per day chemical form selenate , supplemental intake 200 µg selenium selenomethionine . 144 patient cirrhosis randomize one 4 treatment group , include placebo . After treatement 4 week , participant receive 400 µg selenium per day selenate 4 week . Blood measure initially 4 8 week . Selenium , selenoprotein P glutathione peroxidase measure plasma .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Selenic Acid</mesh_term>
	<criteria>adult cirrhosis Pregnancy planning pregnancy Selenium supplement 25 µg within past year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>selenium supplement</keyword>
	<keyword>selenate</keyword>
	<keyword>selenomethionine</keyword>
	<keyword>biomarkers</keyword>
	<keyword>plasma selenium concentration</keyword>
	<keyword>plasma glutathione peroxidase</keyword>
	<keyword>selenoprotein P</keyword>
</DOC>